Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Alzheimer’s blood biomarkers not ready for primary care use, expert panel decides
By
Alicia Lasek
Aug 18, 2022
An international group of clinicians and researchers have agreed that Alzheimer’s disease blood biomarkers are a significant breakthrough, but are not yet ready for general clinical and primary care...